Emergence of OptrA Gene Mediated Linezolid Resistance among Enterococcus Faecium: A Pilot Study from a Tertiary Care Hospital, India
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Vol. 12 (3) , 242-256
Abstract
E. faecium is the third most common cause of nosocomial infections. Linezolid (LNZ) is a reserve antibiotic recommended for infections caused by vancomycin resistant E. faecium (VREfm). The aim of the present study was to investigate the prevalence of optrA gene among linezolid resistant E. faecium (LREfm) and to study the molecular epidemiology using pulse field gel electrophoresis (PFGE). Clinically significant LREfm were identified and antimicrobial susceptibility was performed by disc diffusion. Minimum inhibitory concentration (MIC) of linezolid, vancomycin, daptomycin and quinupristin/dalfopristin was determined by E -test. PCR and PCR-RFPL were performed for the detection of optrA/cfr gene and G2576T mutation respectively. Molecular epidemiology was studied by PFGE. A total of 1081 clinically significant Enterococci species were isolated which included E. faecium 63.5% (n=687) and E. faecalis 36.5% (n=394). LREfm (30/687) were further studied. Multidrug resistance and v ancomycin resistance was 100% and 80%, respectively. Linezolid MIC range was 8-256 mu g/ml and the most common mechanism of resistance was optrA gene (83.3%) followed by G2576T mutation (33.3%). PFGE analysis demonstrated 4 major clones. The optrA gene mediated linezolid resistance was high and PFGE suggests resistance was emerging in the different background strains irrespective of resistance mechanism. Studies are required to investigate factors driving the emergence of linezolid resistance. The review suggests that this is the first report of optrAmediated resistance in E. faecium from India.Keywords
This publication has 43 references indexed in Scilit:
- Modified pulsed‐field gel electrophoresis protocol for typing of enterococciAPMIS, 2002
- Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002.Journal of Antimicrobial Chemotherapy, 2002
- Gene Dosage and Linezolid Resistance in Enterococcus faecium and Enterococcus faecalisAntimicrobial Agents and Chemotherapy, 2002
- The epidemiology of glycopeptide-resistant enterococci on a haematology unit – analysis by pulsed-field gel electrophoresisEpidemiology and Infection, 2002
- The Discovery of Linezolid, the First Oxazolidinone Antibacterial AgentCurrent Drug Targets - Infectious Disorders, 2001
- Resistance to Linezolid: Characterization of Mutations in rRNA and Comparison of Their Occurrences in Vancomycin-Resistant EnterococciAntimicrobial Agents and Chemotherapy, 2001
- A rapid DNA isolation procedure for the identification of Campylobacter jejuni by the polymerase chain reactionLetters in Applied Microbiology, 2000
- Vancomycin-Resistant EnterococciClinical Microbiology Reviews, 2000
- Linezolid--a new option for treating gram-positive infections.2000
- Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the FutureEmerging Infectious Diseases, 1998